Citigroup’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.68K | Sell |
|
|||||
|
2025
Q2 | $44.3K | Buy |
|
|||||
|
2025
Q1 | $9.41K | Sell |
|
|||||
|
2024
Q4 | $149K | Buy |
|
|||||
|
2024
Q3 | $2.4K | Sell |
|
|||||
|
2024
Q2 | $14.8K | Buy |
|
|||||
|
2024
Q1 | $15.3K | Sell |
|
|||||
|
2023
Q4 | $533K | Buy |
|
|||||
|
2023
Q3 | $81.3K | Sell |
|
|||||
|
2023
Q2 | $312K | Sell |
|
|||||
|
2023
Q1 | $619K | Buy |
|
|||||
|
2022
Q4 | $288K | Buy |
|
|||||
|
2022
Q3 | $130K | Sell |
|
|||||
|
2022
Q2 | $187K | Buy |
|
|||||
|
2022
Q1 | $145K | Sell |
|
|||||
|
2021
Q4 | $256K | Sell |
|
|||||
|
2021
Q3 | $438K | Buy |
|
|||||
|
2021
Q2 | $158K | Buy |
|
|||||
|
2021
Q1 | $156K | Sell |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $10K | Buy |
|
|||||
|
2019
Q4 | $12K | Buy |
|
|||||
|
2019
Q3 | $2K | Sell |
|
|||||
|
2019
Q2 | $37K | Buy |
|
|||||
|
2019
Q1 | $79K | Buy |
|
|||||
|
2018
Q4 | $30K | Buy |
|
|||||
|
2018
Q3 | $1K | Buy |
|
|||||
|
2018
Q2 | $1K | Sell |
|
|||||
|
2018
Q1 | $2K | Sell |
|
|||||
|
2017
Q4 | $5K | Buy |
|
|||||
|
2017
Q3 | $2K | Sell |
|
|||||
|
2017
Q2 | $117K | Buy |
|
|||||
|
2017
Q1 | $47K | Sell |
|
|||||
|
2016
Q4 | $311K | Buy |
|
|||||
|
2016
Q3 | $22K | Sell |
|
|||||
|
2016
Q2 | $18K | Sell |
|
|||||
|
2016
Q1 | $161K | Buy |
|
|||||
|
2015
Q4 | $47K | Buy |
|